Imricor Medical Systems Inc - Asset Resilience Ratio

Latest as of December 2025: 46.50%

Imricor Medical Systems Inc (IMR) has an Asset Resilience Ratio of 46.50% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

AU$21.29 Million

≈ $15.07 Million USD Cash + Short-term Investments

Total Assets

AU$45.79 Million

≈ $32.40 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2023–2025)

This chart shows how Imricor Medical Systems Inc's Asset Resilience Ratio has changed over time. Check Imricor Medical Systems Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Imricor Medical Systems Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see IMR company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$21.29 Million	46.5%
Total Liquid Assets	AU$21.29 Million	46.50%

Asset Resilience Insights

Very High Liquidity: Imricor Medical Systems Inc maintains exceptional liquid asset reserves at 46.50% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Imricor Medical Systems Inc Industry Peers by Asset Resilience Ratio

Compare Imricor Medical Systems Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Bio-Rad Laboratories Inc NYSE:BIO	Medical Devices	10.80%
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
Tellgen Corp SHE:300642	Medical Devices	9.96%
Affluent Medical SAS PA:AFME	Medical Devices	0.03%
Cochlear Ltd AU:COH	Medical Devices	9.76%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%
Polynovo Ltd AU:PNV	Medical Devices	0.04%
Avita Medical Inc AU:AVH	Medical Devices	32.24%

Annual Asset Resilience Ratio for Imricor Medical Systems Inc (2023–2025)

The table below shows the annual Asset Resilience Ratio data for Imricor Medical Systems Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	46.50%	AU$21.29 Million ≈ $15.07 Million	AU$45.79 Million ≈ $32.40 Million	+51.16pp
2023-12-31	-4.66%	AU$-387.09K ≈ $-273.89K	AU$8.31 Million ≈ $5.88 Million	--

pp = percentage points

About Imricor Medical Systems Inc

AU:IMR Australia Medical Devices

Market Cap

$465.07 Million

AU$657.29 Million AUD

Market Cap Rank

#12407 Global

#324 in Australia

Share Price

AU$1.86

Change (1 day)

-1.33%

52-Week Range

AU$1.21 - AU$2.20

All Time High

AU$2.79